Cannabinoid CB1 Receptor Expression in Rat Spinal Cord

Farquhar-Smith, W.Paul, Egertová, Michaela, Bradbury, Elizabeth J., McMahon, Stephen B., Rice, Andrew S.C., Elphick, Maurice R.·2000·Molecular and Cellular Neuroscience

Cited by (269)

Items 101–200 of 269

  1. Cannabinoid Therapeutics in Chronic Neuropathic Pain: From Animal Research to Human Treatment
    Raquel Maria Pereira Campos, Andrey F. L. Aguiar, Yolanda Paes-Colli, Priscila Martins Pinheiro Trindade, Bruna Klippel Ferreira, Ricardo Augusto de Melo Reis, Luzia da Silva Sampaio · 2021 · Frontiers in Physiology
  2. Modulation of neuropathic-pain-related behaviour by the spinal endocannabinoid/endovanilloid system
    Katarzyna Starowicz, Barbara Przewłocka · 2012 · Philosophical Transactions of the Royal Society B Biological Sciences
  3. Activation of spinal and supraspinal cannabinoid-1 receptors leads to antinociception in a rat model of neuropathic spinal cord injury pain
    Aldric T. Hama, Jacqueline Sagen · 2011 · Brain Research
  4. Cannabis in Palliative Medicine: Improving Care and Reducing Opioid-Related Morbidity
    Gregory T. Carter, Aaron M. Flanagan, Mitch Earleywine, Donald I. Abrams, Sunil Kumar Aggarwal, Lester Grinspoon · 2011 · American Journal of Hospice and Palliative Medicine®
  5. Acute Reduction of Anandamide‐Hydrolase (FAAH) Activity is Coupled With a Reduction of Nociceptive Pathways Facilitation in Medication‐Overuse Headache Subjects After Withdrawal Treatment
    Armando Perrotta, Natalia Arce‐Leal, Cristina Tassorelli, Valeria Gasperi, Grazia Sances, Fabio Blandini, Mariano Serrao, Monica Bolla, Francesco Pierelli, Giuseppe Nappi et al. · 2012 · Headache The Journal of Head and Face Pain
  6. The cannabinomimetic arachidonyl‐2‐chloroethylamide (ACEA) acts on capsaicin‐sensitive TRPV1 receptors but not cannabinoid receptors in rat joints
    Chris Baker, Jason J. McDougall · 2004 · British Journal of Pharmacology
  7. Endocannabinoid‐dependent plasticity at spinal nociceptor synapses
    Ako Kato, Pradeep Punnakkal, Alejandro J. Pernía‐Andrade, Carolin von Schoultz, Salim Sharopov, Rita Nyilas, István Katona, Hanns Ulrich Zeilhofer · 2012 · The Journal of Physiology
  8. Cannabis and endocannabinoid modulators: Therapeutic promises and challenges
    Igor Grant, B. Rael Cahn · 2005 · Clinical Neuroscience Research
  9. CB1 receptor antagonist SR141716A increases capsaicin‐evoked release of Substance P from the adult mouse spinal cord
    Isobel J. Lever, Marzia Malcangio · 2002 · British Journal of Pharmacology
  10. Central glucocorticoid receptors regulate the upregulation of spinal cannabinoid-1 receptors after peripheral nerve injury in rats
    Wang, Shuxing, Lim, Grewo, Mao, Ji, Sung, Backil, Yang, Liling, Mao, Jianren · 2007 · Pain
  11. The role of cannabinoids in pain modulation in companion animals
    Agatha Elisa Miranda-Cortés, Daniel Mota‐Rojas, Nadia Crosignani, Alejandro Casas-Alvarado, Julio Martı́nez-Burnes, Adriana S Olmos-Hernández, Patricia Mora‐Medina, Antonio Verduzco-Mendoza, Ismael Hernández-Ávalos · 2023 · Frontiers in Veterinary Science
  12. Different effects of opioid and cannabinoid receptor agonists on C-fiber-induced extracellular signal-regulated kinase activation in dorsal horn neurons in normal and spinal nerve-ligated rats
    Kawasaki, Yasuhiko, Kohno, Tatsuro, Ji, Ru-Rong · 2006 · The Journal of Pharmacology and Experimental Therapeutics
  13. The spinal basis of opioid tolerance and physical dependence: Involvement of calcitonin gene-related peptide, substance P, and arachidonic acid-derived metabolites
    Tuan Trang, Rémi Quirion, Khem H. Jhamandas · 2005 · Peptides
  14. The Endocannabinoid System in Pediatric Inflammatory and Immune Diseases
    Maura Argenziano, Chiara Tortora, Giulia Bellini, Alessandra Di Paola, Francesca Punzo, Francesca Rossi · 2019 · International Journal of Molecular Sciences
  15. In vivoeffects of CB2receptor‐selective cannabinoids on the vasculature of normal and arthritic rat knee joints
    Jason J. McDougall, V Postnov Yu, Julie J Thomson · 2007 · British Journal of Pharmacology
  16. Peripheral interactions between cannabinoid and opioid systems contribute to the antinociceptive effect of crotalphine
    Franciele Corrêa Machado, Vanessa O. Zambelli, Ana Campos Fernandes, Andrea S. Heimann, Yara Cury, Gisele Picolo · 2013 · British Journal of Pharmacology
  17. Chronic exposure of sensory neurones to increased levels of nerve growth factor modulates CB1/TRPV1 receptor crosstalk
    Rhian M. Evans, Roderick H. Scott, Ruth A. Ross · 2007 · British Journal of Pharmacology
  18. Antinociceptive effect of cannabinoid agonist WIN 55,212-2 in rats with a spinal cord injury
    Hama, Aldric, Sagen, Jacqueline · 2007 · Experimental Neurology
  19. Spinal administration of capsazepine inhibits noxious evoked responses of dorsal horn neurons in non-inflamed and carrageenan inflamed rats
    Sara Kelly, Victoria Chapman · 2002 · Brain Research
  20. Involvement of cannabinoid (CB1)-receptors in the development and maintenance of opioid tolerance
    Tuan Trang, Maaja Sutak, Khem H. Jhamandas · 2007 · Neuroscience
  21. Reduction of Bone Cancer Pain by Activation of Spinal Cannabinoid Receptor 1 and Its Expression in the Superficial Dorsal Horn of the Spinal Cord in a Murine Model of Bone Cancer Pain
    Shingo Furuse, Tomoyuki Kawamata, Jun Yamamoto, Yukitoshi Niiyama, Keiichi Omote, Masahiko Watanabe, Akiyoshi Namiki · 2009 · Anesthesiology
  22. The endocannabinoid system — a target for the treatment of LUTS?
    Petter Hedlund, Christian Gratzke · 2016 · Nature Reviews Urology
  23. Topical cannabinoid agonist, WIN55,212-2, reduces cornea-evoked trigeminal brainstem activity in the rat
    David A. Bereiter, David A. Bereiter, Harumitsu Hirata · 2002 · Pain
  24. Centrally mediated antinociceptive effects of cannabinoid receptor ligands in rat models of nociception
    Aldric T. Hama, Jacqueline Sagen · 2011 · Pharmacology Biochemistry and Behavior
  25. Cannabinoids in pain and inflammation
    Estery C Mbvundula, Kim Drummond Rainsford, R.A.D. Bunning · 2004 · Inflammopharmacology
  26. The Basic Science of Cannabinoids
    Alexandra Sideris, Justas Lauzadis, Martin Kaczocha · 2023 · Anesthesia & Analgesia
  27. Cannabinoid CB1 receptor facilitation of substance P release in the rat spinal cord, measured as neurokinin 1 receptor internalization
    Guohua Zhang, Wenling Chen, Lijun Lao, Juan Carlos G. Marvizón · 2010 · European Journal of Neuroscience
  28. The neuroprotective role of endocannabinoids against chemical‐induced injury and other adverse effects
    Panagiotis Zogopoulos, Ioanna Vasileiou, Efstratios Patsouris, Stamatios E Theocharis · 2013 · Journal of Applied Toxicology
  29. Dissociation between the panicolytic effect of cannabidiol microinjected into the substantia nigra, pars reticulata, and fear-induced antinociception elicited by bicuculline administration in deep layers of the superior colliculus: The role of CB1-cannabinoid receptor in the ventral mesencephalon
    Juliana Almeida da Silva, Audrey Franceschi Biagioni, Rafael Carvalho Almada, José Alexandre S. Crippa, Jaime E. C. Hallak, Antônio Waldo Zuardi, Norberto Cysne Coimbra · 2015 · European Journal of Pharmacology
  30. Dorsal horn-enriched genes identified by DNA microarray, in situ hybridization and immunohistochemistry
    Hong Bing Sun, Jian Yu Xu, Kimberly B Della Penna, RJ Benz, Fumi Kinose, Daniel Holder, Kenneth S. Koblan, David Lee Gerhold, Hao Wang · 2002 · BMC Neuroscience
  31. Cellular neurochemical characterization and subcellular localization of phospholipase C β1 in rat brain
    Mario Montaña, Gontzal Garcı́a del Caño, Maider López de Jesús, Imanol González‐Burguera, Leyre Echeazarra, Sergio Barrondo, Joan Sallés · 2012 · Neuroscience
  32. Spinal modulation of calcitonin gene-related peptide by endocannabinoids in the development of opioid physical dependence
    Tuan Trang, Weiya Ma, Jean‐Guy Chabot, Rémi Quirion, Khem H. Jhamandas · 2006 · Pain
  33. Role of cannabinoid receptors in the control of gastrointestinal motility and perception
    Jean Fioramonti, Lionel P. Bueno · 2008 · Expert Review of Gastroenterology & Hepatology
  34. Differential distribution of diacylglycerol lipase‐alpha and N‐acylphosphatidylethanolamine‐specific phospholipase d immunoreactivity in the superficial spinal dorsal horn of rats
    Zoltán Hegyi, Krisztina Holló, Gréta Nikoletta Kis, Ken Mackie, Miklós Antal · 2012 · Glia
  35. AM404, an inhibitor of anandamide reuptake decreases Fos-immunoreactivity in the spinal cord of neuropathic rats after non-noxious stimulation
    Rodella, Luigi F., Borsani, Elisa, Rezzani, Rita, Ricci, Francesca, Buffoli, Barbara, Bianchi, Rossella · 2005 · European Journal of Pharmacology
  36. Chronic constriction injury reduces cannabinoid receptor 1 activity in the rostral anterior cingulate cortex of mice
    Michelle R. Hoot, Laura J. Sim‐Selley, Justin L. Poklis, Rehab A. Abdullah, Krista L. Scoggins, Dana E. Selley, William L. Dewey · 2010 · Brain Research
  37. Cannabinoid 1 receptor mediation of spinal cord ischemic tolerance induced by limb remote ischemia preconditioning in rats
    Binxiao Su, Hailong Dong, Rui Ma, Xijing Zhang, Qian Ding, Lize Xiong · 2009 · Journal of Thoracic and Cardiovascular Surgery
  38. HU-210 shows higher efficacy and potency than morphine after intrathecal administration in the mouse formalin test
    Hans Gühring, Johannes Schuster, May Hamza, Mehmet Ateş, Carolin Kotalla, Kay Brune · 2001 · European Journal of Pharmacology
  39. Cannabinoid System in Neurodegeneration: New Perspectives in Alzheimers Disease
    Nuria Eugenia Campillo, Juan Antonio Paez · 2009 · Mini-Reviews in Medicinal Chemistry
  40. Cannabinoids and cancer pain: A new hope or a false dawn?
    Matthew R. D. Brown, W. Paul Farquhar-Smith · 2018 · European Journal of Internal Medicine
  41. The role of cannabinoids in prostate cancer: Basic science perspective and potential clinical applications
    JuanA Ramos, Fernando J. Bianco · 2012 · Indian Journal of Urology
  42. Different Forms of Glycine- and GABAA-Receptor Mediated Inhibitory Synaptic Transmission in Mouse Superficial and Deep Dorsal Horn Neurons
    Wayne B Anderson, Brett Anthony Graham, Natalie Jane Beveridge, Paul A. Tooney, Alan M. Brichta, Robert J. Callister · 2009 · Molecular Pain
  43. Hypotensive effect of anandamide through the activation of CB1 and VR1 spinal receptors in urethane-anesthetized rats
    María del Carmen García, Edda Adler‐Graschinsky, Stella Maris Celuch · 2003 · Naunyn-Schmiedeberg s Archives of Pharmacology
  44. Anandamide inhibits excitatory transmission to rat substantia gelatinosa neurones in a manner different from that of capsaicin
    Ceng Luo, Eiichi Kumamoto, Hidemasa Furue, Jun Chen, Megumu Yoshimura · 2002 · Neuroscience Letters
  45. Cellular and behavioral basis of cannabinioid and opioid interactions: Implications for opioid dependence and withdrawal
    Aida Mohammadkhani, Stephanie L. Borgland · 2020 · Journal of Neuroscience Research
  46. Receptor mechanisms underlying the CNS effects of cannabinoids: CB1 receptor and beyond
    Briana J. Hempel, Zheng‐Xiong Xi · 2022 · Advances in pharmacology
  47. Recent Advances in Endocannabinoid System Targeting for Improved Specificity: Strategic Approaches to Targeted Drug Delivery
    Mendhi Henna Dasram, Roderick B. Walker, Sandile Maswazi Khamanga · 2022 · International Journal of Molecular Sciences
  48. Effect of Cannabis on Memory Consolidation, Learning and Retrieval and Its Current Legal Status in India: A Review
    Nandi Niloy, Tousif Ahmed Hediyal, Chandrasekaran Vichitra, Sonali Sharma, Saravana Babu Chidambaram, Vasavi Rakesh Gorantla, Arehally Marappa Mahalakshmi · 2023 · Biomolecules
  49. The Endocannabinoid Anandamide Inhibits Voltage-Gated Sodium Channels Nav1.2, Nav1.6, Nav1.7, and Nav1.8 in Xenopus Oocytes
    Dan Okura, Takafumi Horishita, Susumu Ueno, Nobuyuki Yanagihara, Yuka Sudo, Yasuhito Uezono, Takeyoshi Sata · 2014 · Anesthesia & Analgesia
  50. Endocannabinoids Part I: Molecular basis of endocannabinoid formation, action and inactivation and development of selective inhibitors
    O Vincenzo Di Marzo, Luciano De PETROCELLIS, Tiziana Bisogno · 2001 · Emerging Therapeutic Targets
  51. New perspectives on the role of the neurosteroid pregnenolone as an endogenous regulator of type‐1 cannabinoid receptor (CB1R) activity and function
    Pierre‐Louis Raux, Guillaume Drutel, Jean‐Michel Revest, Monique Vallée · 2021 · Journal of Neuroendocrinology
  52. Cannabinoids to treat spinal cord injury
    Ángel Arévalo‐Martín, Eduardo Molina‐Holgado, Daniel García‐Ovejero · 2015 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  53. CB1 cannabinoid receptors in amphibian spinal cord: relationships with some nociception markers
    Chiara Salio, Erika Cottone, Marie Conrath, Maria Fosca Franzoni · 2002 · Journal of Chemical Neuroanatomy
  54. Functional changes in the inhibitory effect of spinal cannabinoid (CB) receptor activation in nerve injured rats
    Chapman, V. · 2001 · Neuropharmacology
  55. From a Designer Drug to the Discovery of Selective Cannabinoid Type 2 Receptor Agonists with Favorable Pharmacokinetic Profiles for the Treatment of Systemic Sclerosis
    Beier Jiang, Xingwu Jiang, Qiansen Zhang, Qiuwen Liang, Zi-Liang Qiu, Xiang-Bai Sun, Junjie Yang, Si Chen, Chunyang Yi, Xiaolei Chai et al. · 2020 · Journal of Medicinal Chemistry
  56. Differential glutamatergic and GABAergic contributions to the tetrad effects of Δ9-tetrahydrocannabinol revealed by cell-type-specific reconstitution of the CB1 receptor
    Vanessa De Giacomo, Sabine Ruehle, Beat Lutz, Martin Häring, Floortje Remmers · 2020 · Neuropharmacology
  57. The endocannabinoid and endovanilloid systems and their interactions in neuropathic pain
    Sabatino Maione, Katarzyna Starowicz, Enza Palazzo, Francesco Rossi, Vincenzo Di Marzo · 2006 · Drug Development Research
  58. Role of Cannabinoids in the Management of Neuropathic Pain
    María Isabel Martín Fontelles, Carlos Goicoechea · 2008 · CNS Drugs
  59. Central glucocorticoid receptors modulate the expression of spinal cannabinoid receptors induced by chronic morphine exposure
    Grewo Lim, Shuxing Wang, Jianren Mao · 2005 · Brain Research
  60. A cell population that strongly expresses the CB1 cannabinoid receptor in the ependyma of the rat spinal cord
    Daniel García‐Ovejero, Ángel Arévalo‐Martín, Beatriz Paniagua‐Torija, Yolanda Sierra‐Palomares, Eduardo Molina‐Holgado · 2012 · The Journal of Comparative Neurology
  61. Antinociceptive effect of spinally administered cannabinergic and 2-adrenoceptor drugs on the formalin test in rat: possible interactions
    Mohammad Javad Khodayar, Bijan Shafaghi, Nima Naderi, Mohammad‐Reza Zarrindast · 2005 · Journal of Psychopharmacology
  62. The induction of long-term potentiation in spinal dorsal horn after peripheral nociceptive stimulation and contribution of spinal TRPV1 in rats
    Fei Yang, Jie Guo, W.-L. Sun, F.Y. Liu, Jie Cai, Guo‐Gang Xing, You Wan · 2014 · Neuroscience
  63. Inverse relation between intensity of GFAP expression in the substantia gelatinosa and degree of chronic mechanical allodynia
    Ronald Deumens, Robby J.P. Jaken, Liesbeth Knaepen, Inge van der Meulen, Elbert A.J. Joosten · 2009 · Neuroscience Letters
  64. Cannabinoid Agonist, CP 55,940, Prevents Capsaicin-Induced Sensitization of Spinal Cord Dorsal Horn Neurons
    Lisa M. Johanek, Donald A. Simone · 2004 · Journal of Neurophysiology
  65. Cannabinoid 1 receptor knockout mice display cold allodynia, but enhanced recovery from spared-nerve injury-induced mechanical hypersensitivity
    Alexandra Sideris, Boris Piskoun, Lori Russo, Monica Norcini, Thomas J. J. Blanck, Esperanza Recio‐Pinto · 2016 · Molecular Pain
  66. Cannabinoid and Vanilloid Effects of R(+)-Methanandamide in the Hemisected Meningeal Preparation
    MJM Fischer, Karl Meßlinger · 2007 · Cephalalgia
  67. Sphingosine lysolipids in the CNS: Endogenous cannabinoid antagonists or a parallel pain modulatory system?
    Dana E. Selley, Sandra P. Welch, Laura J. Sim‐Selley · 2013 · Life Sciences
  68. Endocannabinoids Mediate Tachykinin-Induced Effects in the Lamprey Locomotor Network
    Carolina Thörn Pérez, Russell H. Hill, Abdeljabbar El Manira, Sten E. Grillner · 2009 · Journal of Neurophysiology
  69. Behavioral and Electrophysiological Evidence for the Differential Functions of TRPV1 at Early and Late Stages of Chronic Inflammatory Nociception in Rats
    Hao Luo, Isabella Shi Xu, Yi Chen, Fei Yang, Lu Yu, Guangxin Li, Fengyu Liu, Guo‐Gang Xing, Yu-Shun Shi, Li Tan et al. · 2008 · Neurochemical Research
  70. Peripheral inflammation affects modulation of nociceptive synaptic transmission in the spinal cord induced by N‐arachidonoylphosphatidylethanolamine
    Vladimír Nerandžič, Petra Mrózková, Pavel Adámek, Diana Spicarova, I. Nagy, Jiřı́ Paleček · 2017 · British Journal of Pharmacology
  71. Pharmacologie des dérivés cannabinoïdes : applications au traitement de la douleur ?
    Pierre Beaulieu, Andrew S.C. Rice · 2002 · Annales Françaises d Anesthésie et de Réanimation
  72. The expression of the Peripheral Cannabinoid receptor on cells of the immune system and Non-Hodgkin's lymphomas
    Nazik Rayman, King Hong Lam, Joost Van Leeuwen, Andries H. Mulder, Leo M. Budel, Bob Löwenberg, Pieter Sonneveld, Ruud Delwel · 2007 · Leukemia & lymphoma/Leukemia and lymphoma
  73. Localization of CiCBR in the invertebrate chordate Ciona intestinalis: Evidence of an ancient role for cannabinoid receptors as axonal regulators of neuronal signalling
    Michaela Egertová, Maurice R. Elphick · 2007 · The Journal of Comparative Neurology
  74. Functional Organization of Dorsal Horn Interneurons
    William D. Willis, Richard E. Coggeshall · 2004 · Springer eBooks
  75. Cannabinoid CB1 receptor inhibition of mechanically evoked responses of spinal neurones in control rats, but not in rats with hindpaw inflammation
    Sara Kelly, Victoria Chapman · 2003 · European Journal of Pharmacology
  76. Do cannabinoids have a role in cancer pain management?
    W. Paul Farquhar-Smith · 2009 · Current Opinion in Supportive and Palliative Care
  77. From Active Ingredients to the Discovery of the Targets: The Cannabinoid Receptors
    Ken Mackie · 2007 · Chemistry & Biodiversity
  78. History of Cannabis as Medicine: Nineteenth Century Irish Physicians and Correlations of Their Observations to Modern Research
    Ethan B. Russo · 2017 · Springer eBooks
  79. Physiological evidence of a postsynaptic inhibition of the tail flick reflex by a cannabinoid receptor agonist
    Liliane J. Dableh, Kiran Yashpal, James L. Henry · 2008 · European Journal of Pharmacology
  80. Cannabinoids: Role in Neurological Diseases and Psychiatric Disorders
    Ujendra Kumar · 2024 · International Journal of Molecular Sciences
  81. Cannabinoid CB1 Receptor Expression and Localization in the Dorsal Horn of Male and Female Rat and Human Spinal Cord
    Jessica Parnell, Newton Martin, Annemarie Dedek, Chris Rudyk, Jeffrey Landrigan, Justin Bellavance, Simon VanDerLoo, Eve Chung Tsai, Michael E. Hildebrand · 2023 · Canadian Journal of Pain
  82. Cannabinoid Analgesia in Postoperative Pain Management: From Molecular Mechanisms to Clinical Reality
    Antonio J. Carrascosa, Francisco Navarrete, Raquel Saldaña, María S. García‐Gutiérrez, Belinda Montalbán Moreno, Daniela Navarro, Fernando M. Gómez-Guijarro, Ani Gasparyan, Elena Murcia-Sánchez, Abraham B. Torregrosa et al. · 2024 · International Journal of Molecular Sciences
  83. The peripheral cannabinoid receptor 1 antagonist VD60 efficiently inhibits carbon tetrachloride-intoxicated hepatic fibrosis progression
    Wei Xing Yan, Xiaoli Kang, Xu Wang · 2014 · Experimental Biology and Medicine
  84. Effect of nucleus accumbens shell 5-HT4 receptors on the impairment of ACPA-induced emotional memory consolidation in male Wistar rats
    Ebrahim Khodayar, Shahrbanoo Oryan, Mohammad Nasehi, Mohammad‐Reza Zarrindast · 2015 · Behavioural Pharmacology
  85. Prediction and Experimental Confirmation of Novel Peripheral Cannabinoid‑1 Receptor Antagonists
    Shayma El-Atawneh, Shira Hirsch, Rivka Hadar, Joseph Tam, Amiram Goldblum · 2019 · Journal of Chemical Information and Modeling
  86. The contribution of VR1 and CB1 receptors and the role of the afferent vagal pathway in modelling of cardio-respiratory effects of anandamide in rats
    Beata Kopczyńska · 2007 · Life Sciences
  87. Cannabinoids and analgesia
    J.W Brooks · 2002 · Current Anaesthesia and Critical Care
  88. High hopes for cannabinoid analgesia
    Geoff Watts · 2004 · BMJ
  89. Peripherally restricted cannabinoid and mu-opioid receptor agonists synergistically attenuate neuropathic mechanical hypersensitivity in mice
    Gerard Limerick, Ankit Uniyal, Neil C. Ford, Shao-Qiu He, Shaness A. Grenald, Chi Zhang, Xiang Cui, Eellan Sivanesan, Xinzhong Dong, Yun Guan et al. · 2024 · Pain
  90. CB1 receptor antagonism/inverse agonism increases motor system excitability in humans.
    A. Oliviero, A. Arevalo‐Martin, M. Rotondi, D. Garcia-Ovejero, L. Mordillo-Mateos, A. Lozano-Sicilia, I. Panyavin, L. Chiovato, J. Aguilar, G. Foffani et al. · 2012 · European Neuropsychopharmacology
  91. Therapeutic Targeting of Peripheral Cannabinoid Receptors in Inflammatory and Neuropathic Pain States
    Igor Spigelman · 2009 · Frontiers in neuroscience
  92. The antinociceptive potency of N-arachidonoyl-dopamine (NADA) and its interaction with endomorphin-1 at the spinal level
    Ibolya G. Farkas, Gábor Tuboly, György Benedek, Gyöngyi Horváth · 2011 · Pharmacology Biochemistry and Behavior
  93. N-adamantyl-anthranil amide derivatives: New selective ligands for the cannabinoid receptor subtype 2 (CB2R)
    Giovanni Graziano, Pietro Delre, Francesca Carofiglio, Jose Manuel Brea, Alessia Ligresti, Magdalena Kostrzewa, Chiara Riganti, Claudia Gioé-Gallo, María Majellaro, Orazio Nicolotti et al. · 2023 · European Journal of Medicinal Chemistry
  94. The effect of chronic opioid vs. cannabinoid exposure on the expression of tolerance to morphine- or WIN-55,212-2-induced analgesia and hypothermia in the guinea pig
    Hercules Tarambirwa Maguma, DAVID A H B TAYLOR · 2011 · European Journal of Pharmacology
  95. Electroacupuncture Alleviates Hyperalgesia by Regulating CB1 Receptor of Spinal Cord in Incisional Neck Pain Rats
    Junying Wang, Jinling Zhang, Yonghui Gao, Yu Chen, Cheng-Lin Duanmu, Junling Liu · 2021 · Evidence-based Complementary and Alternative Medicine
  96. Cannabinoids for SARS-CoV-2 and is there evidence of their therapeutic efficacy?
    Ahmet Onay, Abdülselam Ertaş, Veysel Süzerer, İsmail Yener, Mustafa Abdullah Yılmaz, Emine Ayaz Tilkat, Remzi Ekıncı, Nesrin Bozhan, Sevgi İrtegün Kandemir · 2021 · TURKISH JOURNAL OF BIOLOGY
  97. Effect of cannabinoids on CGRP release in the isolated rat lumbar spinal cord
    Michael Milne, John C. Ashton · 2016 · Neuroscience Letters
  98. Upregulation of fatty acid amide hydrolase in the dorsal periaqueductal gray is associated with neuropathic pain and reduced heart rate in rats
    Caron Dean, Cecilia J. Hillard, Jeanne L. Seagard, Francis A. Hopp, Quinn H. Hogan · 2017 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
  99. Effects of WIN55,212-2 on voltage-gated sodium channels in trigeminal ganglion neurons of rats
    Hui Fu, Jian Min Xiao, Xue Cao, Zhang Yin Ming, Lie Ju Liu · 2008 · Neurological Research
  100. Non-CB1, Non-CB2 Receptors for Endocannabinoids
    Luciano De PETROCELLIS, Vincenzo Di Marzo · 2005 · CRC Press eBooks